Australia’s CSL has announced plans to expand its US presence over the next five years, resulting in approximately $1.5 ...

The US Food and Drug Administration today announced it has approved Danish biotech firm Genmab’s Epkinly (epcoritamab-bysp) ...

Spanish plasma-based medicines producer Grifols today announced that the US Food and Drug Administration (FDA) has approved ...

South Korean clinical-stage biotech ABL Bio has entered license, research and collaboration agreement with US pharma major ...

Swiss generics and biosimilars company Sandoz has announced the launch of Tyruko (natalizumab-sztn) in the USA.

India’s Zydus Lifesciences has received final approval from the US Food and Drug Administration (FDA) for diroximel fumarate delayed-release capsules, 231mg (Biogen’s Vumerity delayed-release capsules ...

A major British initiative is set to repurpose used nuclear materials, converting them into a consistent supply for ...

Shares of US clinical-stage biopharmaceutical company Nuvalent jumped more than 15% to $111.22 by midday yesterday, after it ...

South Korean biosimilars developer Celltrion today announced that the European Commission (EC) has granted marketing ...

Canadian firm Zymeworks, a biotech managing a portfolio of licensed healthcare assets while developing a diverse pipeline of ...

US industry group PhRMA says three years of Inflation Reduction Act implementation have coincided with rising Medicare Part D premiums, fewer standalone plans and growing barriers to treatment. The ...

New government funding will help make the boldest ideas in UK life sciences a reality – from putting robots to work in ...